About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Pharmaceutical Patent Analyst
›
top-articles
Pharmaceutical Patent Analyst
0.4
(top 50%)
impact factor
377
(top 50%)
papers
2.3K
(top 50%)
citations
21
(top 50%)
h
-index
0.9
(top 50%)
impact factor
548
all documents
2.5K
doc citations
37
(top 20%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Medicinal importance of gallic acid and its ester derivatives: a patent review
Pharmaceutical Patent Analyst
2015
204
2
Therapeutic charm of quercetin and its derivatives: a review of research and patents
Pharmaceutical Patent Analyst
2018
89
3
The A to Z of pharmaceutical cocrystals: a decade of fast-moving new science and patents
Pharmaceutical Patent Analyst
2012
84
4
Mangiferin: a promising anticancer bioactive
Pharmaceutical Patent Analyst
2016
68
5
Current trends in the development of wound dressings, biomaterials and devices
Pharmaceutical Patent Analyst
2013
59
6
Formulation strategies to improve oral peptide delivery
Pharmaceutical Patent Analyst
2014
56
7
Na
+
/K
+
-ATPase and cancer
Pharmaceutical Patent Analyst
2012
52
8
Pharmaceutical and biomedical applications of lipid-based nanocarriers
Pharmaceutical Patent Analyst
2014
52
9
Inhaled antibiotics to treat lung infection
Pharmaceutical Patent Analyst
2013
44
10
Small-molecule inhibitors of IκB kinase (IKK) and IKK-related kinases
Pharmaceutical Patent Analyst
2013
43
11
Transient receptor potential ankyrin 1 (TRPA1) antagonists
Pharmaceutical Patent Analyst
2015
42
12
Inhibitors of voltage-gated sodium channel Na
v
1.7: patent applications since 2010
Pharmaceutical Patent Analyst
2014
37
13
Inhibitors of emerging epigenetic targets for cancer therapy: a patent review (2010–2014)
Pharmaceutical Patent Analyst
2015
36
14
Small-molecule arginase inhibitors
Pharmaceutical Patent Analyst
2014
35
15
Celastrol as a pentacyclic triterpenoid with chemopreventive properties
Pharmaceutical Patent Analyst
2018
34
16
Lipid-based nanocarriers for drug delivery and targeting: a patent survey of methods of production and characterization
Pharmaceutical Patent Analyst
2013
33
17
Targeting inflammation: multiple innovative ways to reduce prostaglandin E2
Pharmaceutical Patent Analyst
2013
31
18
P2X7 antagonists for CNS indications: recent patent disclosures
Pharmaceutical Patent Analyst
2017
27
19
Toward isozyme-selective inhibitors of histone deacetylase as therapeutic agents for the treatment of cancer
Pharmaceutical Patent Analyst
2012
25
20
Metabotropic glutamate receptor 5-positive allosteric modulators for the treatment of schizophrenia (2004–2012)
Pharmaceutical Patent Analyst
2013
25
21
Recent advances in vaccine delivery
Pharmaceutical Patent Analyst
2016
24
22
Pharmacological chaperones for enzyme enhancement therapy in genetic diseases
Pharmaceutical Patent Analyst
2013
23
23
PDK1 inhibitors
Pharmaceutical Patent Analyst
2012
22
24
Approaches targeting the FGF–FGFR system: a review of the recent patent literature and associated advanced therapeutic agents
Pharmaceutical Patent Analyst
2014
22
25
Monoclonal antibodies based on hybridoma technology
Pharmaceutical Patent Analyst
2013
20
26
SGLT inhibitors: a novel target for diabetes
Pharmaceutical Patent Analyst
2013
20
27
Humira: the impending patent battles over adalimumab biosimilars
Pharmaceutical Patent Analyst
2016
20
28
Current patent and clinical status of stimulator of interferon genes (STING) agonists for cancer immunotherapy
Pharmaceutical Patent Analyst
2019
20
29
Antibody–drug conjugates in tumor therapy
Pharmaceutical Patent Analyst
2012
19
30
Current trends in the development of histone deacetylase inhibitors: a review of recent patent applications
Pharmaceutical Patent Analyst
2012
19
31
Advances in recent patent and clinical trial drug development for Alzheimer’s disease
Pharmaceutical Patent Analyst
2014
19
32
Oral insulin-delivery system for diabetes mellitus
Pharmaceutical Patent Analyst
2015
18
33
Novel platinum compounds and nanoparticles as anticancer agents
Pharmaceutical Patent Analyst
2018
18
34
Selective and nonselective HDAC8 inhibitors: a therapeutic patent review
Pharmaceutical Patent Analyst
2018
17
35
Integrated continuous manufacturing in pharmaceutical industry: current evolutionary steps toward revolutionary future
Pharmaceutical Patent Analyst
2019
17
36
Toward selective TYK2 inhibitors as therapeutic agents for the treatment of inflammatory diseases
Pharmaceutical Patent Analyst
2014
16
37
Novel treatment strategies for brain tumors and metastases
Pharmaceutical Patent Analyst
2014
16
38
Recent advances in irreversible kinase inhibitors
Pharmaceutical Patent Analyst
2014
16
39
Glucokinase activators
Pharmaceutical Patent Analyst
2012
15
40
Nanocoatings on implantable medical devices
Pharmaceutical Patent Analyst
2013
15
41
Metabotropic glutamate receptor 5-negative allosteric modulators for the treatment of psychiatric and neurological disorders (2009–July 2013)
Pharmaceutical Patent Analyst
2013
15
42
ENaC inhibitors for the treatment of cystic fibrosis
Pharmaceutical Patent Analyst
2015
15
43
Novel drug therapies in myeloid leukemia: a patent review
Pharmaceutical Patent Analyst
2015
15
44
Toward carbon monoxide based therapeutics: carbon monoxide in a pill
Pharmaceutical Patent Analyst
2017
15
45
Ca
2+
release-activated Ca
2+
channel inhibitors
Pharmaceutical Patent Analyst
2014
14
46
Baicalein: promising therapeutic applications with special reference to published patents
Pharmaceutical Patent Analyst
2022
14
47
The impact of effective patents on future innovations in nanomedicine
Pharmaceutical Patent Analyst
2012
13
48
Small-molecule antagonists of the orexin receptors
Pharmaceutical Patent Analyst
2014
13
49
A comprehensive review of patented antileishmanial agents
Pharmaceutical Patent Analyst
2015
13
50
Fluorine-18 patents (2009–2015). Part 2: new radiochemistry
Pharmaceutical Patent Analyst
2016
13
site/software ©
exaly
; All materials licenced under
CC by-SA
.